Trials / Terminated
TerminatedNCT02204709
Disease Risk Reduction and Omega-3 Rich Rainbow Trout (Fish for Health)
Disease Risk Reduction and n-3 Rich Rainbow Trout (Fish for Health)
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 29 (actual)
- Sponsor
- USDA Grand Forks Human Nutrition Research Center · Federal
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine how eating fish raised to have different levels of omega-3 fatty acids will reduce cardiovascular risk markers in people with elevated cardiovascular risk.
Detailed description
Consumption of fish high in long chain omega-3 fatty acids (LCn3) is associated with reduction of cardiovascular disease (CVD) risk. CVD is a major cause of death in the United States. The current obesity epidemic contributes significantly to elevated CVD risk by increasing inflammation and platelet dysfunction. Prevention of CVD is a public health goal and comprises several avenues of action, of which inclusion of LCn3-rich fish in the diet may be one of the most effective. Obese participants will participate in a double blind, randomized, cross-over designed trial in which they will consume twice-weekly a prepared meal containing diploid (2N) farmed rainbow trout, triploid (3N) farmed rainbow trout containing higher levels of LCn3, or tilapia, a low LCn3 fish.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | 2N Trout | Diploid/2N trout source |
| OTHER | 3N Trout | Triploid/3N trout source |
| OTHER | Tilapia | Tilapia/control fish source |
Timeline
- Start date
- 2015-06-01
- Primary completion
- 2020-03-25
- Completion
- 2020-03-25
- First posted
- 2014-07-30
- Last updated
- 2022-08-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02204709. Inclusion in this directory is not an endorsement.